Global and United States Valeramide (CAS 626-97-1) Market Report & Forecast 2023-2028

Report ID: 1827461 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Valeramide (CAS 626-97-1) Product Introduction
    1.2 Global Valeramide (CAS 626-97-1) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Valeramide (CAS 626-97-1) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Valeramide (CAS 626-97-1) Sales in Volume for the Year 2017-2028
    1.3 United States Valeramide (CAS 626-97-1) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Valeramide (CAS 626-97-1) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Valeramide (CAS 626-97-1) Sales in Volume for the Year 2017-2028
    1.4 Valeramide (CAS 626-97-1) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Valeramide (CAS 626-97-1) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Valeramide (CAS 626-97-1) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Valeramide (CAS 626-97-1) Market Dynamics
        1.5.1 Valeramide (CAS 626-97-1) Industry Trends
        1.5.2 Valeramide (CAS 626-97-1) Market Drivers
        1.5.3 Valeramide (CAS 626-97-1) Market Challenges
        1.5.4 Valeramide (CAS 626-97-1) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Valeramide (CAS 626-97-1) Market Segment by Type
        2.1.1 Purity 97%
        2.1.2 Purity 98%
        2.1.3 Purity 99%
    2.2 Global Valeramide (CAS 626-97-1) Market Size by Type
        2.2.1 Global Valeramide (CAS 626-97-1) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Valeramide (CAS 626-97-1) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Valeramide (CAS 626-97-1) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Valeramide (CAS 626-97-1) Market Size by Type
        2.3.1 United States Valeramide (CAS 626-97-1) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Valeramide (CAS 626-97-1) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Valeramide (CAS 626-97-1) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Valeramide (CAS 626-97-1) Market Segment by Application
        3.1.1 Chemical Reagents
        3.1.2 Pharmaceutical Intermediates
        3.1.3 Others
    3.2 Global Valeramide (CAS 626-97-1) Market Size by Application
        3.2.1 Global Valeramide (CAS 626-97-1) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Valeramide (CAS 626-97-1) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Valeramide (CAS 626-97-1) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Valeramide (CAS 626-97-1) Market Size by Application
        3.3.1 United States Valeramide (CAS 626-97-1) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Valeramide (CAS 626-97-1) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Valeramide (CAS 626-97-1) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Valeramide (CAS 626-97-1) Competitor Landscape by Company
    4.1 Global Valeramide (CAS 626-97-1) Market Size by Company
        4.1.1 Top Global Valeramide (CAS 626-97-1) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Valeramide (CAS 626-97-1) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Valeramide (CAS 626-97-1) Sales by Manufacturer (2017-2022)
        4.1.4 Global Valeramide (CAS 626-97-1) Price by Manufacturer (2017-2022)
    4.2 Global Valeramide (CAS 626-97-1) Concentration Ratio (CR)
        4.2.1 Valeramide (CAS 626-97-1) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Valeramide (CAS 626-97-1) in 2021
        4.2.3 Global Valeramide (CAS 626-97-1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Valeramide (CAS 626-97-1) Manufacturing Base Distribution, Product Type
        4.3.1 Global Valeramide (CAS 626-97-1) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Valeramide (CAS 626-97-1) Product Type
        4.3.3 Date of International Manufacturers Enter into Valeramide (CAS 626-97-1) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Valeramide (CAS 626-97-1) Market Size by Company
        4.5.1 Top Valeramide (CAS 626-97-1) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Valeramide (CAS 626-97-1) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Valeramide (CAS 626-97-1) Sales by Players (2020, 2021 & 2022)
5 Global Valeramide (CAS 626-97-1) Market Size by Region
    5.1 Global Valeramide (CAS 626-97-1) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Valeramide (CAS 626-97-1) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Valeramide (CAS 626-97-1) Sales in Volume by Region: 2017-2022
        5.2.2 Global Valeramide (CAS 626-97-1) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Valeramide (CAS 626-97-1) Market Size in Value by Region (2017-2028)
        5.3.1 Global Valeramide (CAS 626-97-1) Sales in Value by Region: 2017-2022
        5.3.2 Global Valeramide (CAS 626-97-1) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Valeramide (CAS 626-97-1) Market Size YoY Growth 2017-2028
        6.1.2 North America Valeramide (CAS 626-97-1) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Valeramide (CAS 626-97-1) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Valeramide (CAS 626-97-1) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Valeramide (CAS 626-97-1) Market Size YoY Growth 2017-2028
        6.3.2 Europe Valeramide (CAS 626-97-1) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Valeramide (CAS 626-97-1) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Valeramide (CAS 626-97-1) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Valeramide (CAS 626-97-1) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Valeramide (CAS 626-97-1) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 TCI
        7.1.1 TCI Corporation Information
        7.1.2 TCI Description and Business Overview
        7.1.3 TCI Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 TCI Valeramide (CAS 626-97-1) Products Offered
        7.1.5 TCI Recent Development
    7.2 Alfa Chemistry
        7.2.1 Alfa Chemistry Corporation Information
        7.2.2 Alfa Chemistry Description and Business Overview
        7.2.3 Alfa Chemistry Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Alfa Chemistry Valeramide (CAS 626-97-1) Products Offered
        7.2.5 Alfa Chemistry Recent Development
    7.3 Acros Organics
        7.3.1 Acros Organics Corporation Information
        7.3.2 Acros Organics Description and Business Overview
        7.3.3 Acros Organics Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Acros Organics Valeramide (CAS 626-97-1) Products Offered
        7.3.5 Acros Organics Recent Development
    7.4 AlliChem
        7.4.1 AlliChem Corporation Information
        7.4.2 AlliChem Description and Business Overview
        7.4.3 AlliChem Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 AlliChem Valeramide (CAS 626-97-1) Products Offered
        7.4.5 AlliChem Recent Development
    7.5 Waterstone Technology
        7.5.1 Waterstone Technology Corporation Information
        7.5.2 Waterstone Technology Description and Business Overview
        7.5.3 Waterstone Technology Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Waterstone Technology Valeramide (CAS 626-97-1) Products Offered
        7.5.5 Waterstone Technology Recent Development
    7.6 City Chemical
        7.6.1 City Chemical Corporation Information
        7.6.2 City Chemical Description and Business Overview
        7.6.3 City Chemical Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 City Chemical Valeramide (CAS 626-97-1) Products Offered
        7.6.5 City Chemical Recent Development
    7.7 3B Scientific
        7.7.1 3B Scientific Corporation Information
        7.7.2 3B Scientific Description and Business Overview
        7.7.3 3B Scientific Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 3B Scientific Valeramide (CAS 626-97-1) Products Offered
        7.7.5 3B Scientific Recent Development
    7.8 VWR International
        7.8.1 VWR International Corporation Information
        7.8.2 VWR International Description and Business Overview
        7.8.3 VWR International Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 VWR International Valeramide (CAS 626-97-1) Products Offered
        7.8.5 VWR International Recent Development
    7.9 Pfaltz & Bauer
        7.9.1 Pfaltz & Bauer Corporation Information
        7.9.2 Pfaltz & Bauer Description and Business Overview
        7.9.3 Pfaltz & Bauer Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Pfaltz & Bauer Valeramide (CAS 626-97-1) Products Offered
        7.9.5 Pfaltz & Bauer Recent Development
    7.10 Kanto Chemical
        7.10.1 Kanto Chemical Corporation Information
        7.10.2 Kanto Chemical Description and Business Overview
        7.10.3 Kanto Chemical Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Kanto Chemical Valeramide (CAS 626-97-1) Products Offered
        7.10.5 Kanto Chemical Recent Development
    7.11 J & K SCIENTIFIC
        7.11.1 J & K SCIENTIFIC Corporation Information
        7.11.2 J & K SCIENTIFIC Description and Business Overview
        7.11.3 J & K SCIENTIFIC Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 J & K SCIENTIFIC Valeramide (CAS 626-97-1) Products Offered
        7.11.5 J & K SCIENTIFIC Recent Development
    7.12 Meryer (Shanghai) Chemical Technology
        7.12.1 Meryer (Shanghai) Chemical Technology Corporation Information
        7.12.2 Meryer (Shanghai) Chemical Technology Description and Business Overview
        7.12.3 Meryer (Shanghai) Chemical Technology Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Meryer (Shanghai) Chemical Technology Products Offered
        7.12.5 Meryer (Shanghai) Chemical Technology Recent Development
    7.13 Energy Chemical
        7.13.1 Energy Chemical Corporation Information
        7.13.2 Energy Chemical Description and Business Overview
        7.13.3 Energy Chemical Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Energy Chemical Products Offered
        7.13.5 Energy Chemical Recent Development
    7.14 Adamas Reagent
        7.14.1 Adamas Reagent Corporation Information
        7.14.2 Adamas Reagent Description and Business Overview
        7.14.3 Adamas Reagent Valeramide (CAS 626-97-1) Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Adamas Reagent Products Offered
        7.14.5 Adamas Reagent Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Valeramide (CAS 626-97-1) Industry Chain Analysis
    8.2 Valeramide (CAS 626-97-1) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Valeramide (CAS 626-97-1) Distributors
    8.3 Valeramide (CAS 626-97-1) Production Mode & Process
    8.4 Valeramide (CAS 626-97-1) Sales and Marketing
        8.4.1 Valeramide (CAS 626-97-1) Sales Channels
        8.4.2 Valeramide (CAS 626-97-1) Distributors
    8.5 Valeramide (CAS 626-97-1) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Valeramide (CAS 626-97-1) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Valeramide (CAS 626-97-1) Market Trends
    Table 3. Valeramide (CAS 626-97-1) Market Drivers
    Table 4. Valeramide (CAS 626-97-1) Market Challenges
    Table 5. Valeramide (CAS 626-97-1) Market Restraints
    Table 6. Global Valeramide (CAS 626-97-1) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Valeramide (CAS 626-97-1) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Valeramide (CAS 626-97-1) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Valeramide (CAS 626-97-1) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Valeramide (CAS 626-97-1) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Valeramide (CAS 626-97-1) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Valeramide (CAS 626-97-1) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Valeramide (CAS 626-97-1) Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Valeramide (CAS 626-97-1) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Valeramide (CAS 626-97-1) Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Valeramide (CAS 626-97-1) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Valeramide (CAS 626-97-1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valeramide (CAS 626-97-1) as of 2021)
    Table 18. Top Players of Valeramide (CAS 626-97-1) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Valeramide (CAS 626-97-1) Product Type
    Table 20. Date of International Manufacturers Enter into Valeramide (CAS 626-97-1) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Valeramide (CAS 626-97-1) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Valeramide (CAS 626-97-1) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Valeramide (CAS 626-97-1) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Valeramide (CAS 626-97-1) Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Valeramide (CAS 626-97-1) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Valeramide (CAS 626-97-1) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Valeramide (CAS 626-97-1) Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Valeramide (CAS 626-97-1) Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Valeramide (CAS 626-97-1) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Valeramide (CAS 626-97-1) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Valeramide (CAS 626-97-1) Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Valeramide (CAS 626-97-1) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Valeramide (CAS 626-97-1) Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Valeramide (CAS 626-97-1) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Valeramide (CAS 626-97-1) Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Valeramide (CAS 626-97-1) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Valeramide (CAS 626-97-1) Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Valeramide (CAS 626-97-1) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Valeramide (CAS 626-97-1) Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Valeramide (CAS 626-97-1) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. TCI Corporation Information
    Table 43. TCI Description and Business Overview
    Table 44. TCI Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. TCI Valeramide (CAS 626-97-1) Product
    Table 46. TCI Recent Development
    Table 47. Alfa Chemistry Corporation Information
    Table 48. Alfa Chemistry Description and Business Overview
    Table 49. Alfa Chemistry Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Alfa Chemistry Product
    Table 51. Alfa Chemistry Recent Development
    Table 52. Acros Organics Corporation Information
    Table 53. Acros Organics Description and Business Overview
    Table 54. Acros Organics Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Acros Organics Product
    Table 56. Acros Organics Recent Development
    Table 57. AlliChem Corporation Information
    Table 58. AlliChem Description and Business Overview
    Table 59. AlliChem Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. AlliChem Product
    Table 61. AlliChem Recent Development
    Table 62. Waterstone Technology Corporation Information
    Table 63. Waterstone Technology Description and Business Overview
    Table 64. Waterstone Technology Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Waterstone Technology Product
    Table 66. Waterstone Technology Recent Development
    Table 67. City Chemical Corporation Information
    Table 68. City Chemical Description and Business Overview
    Table 69. City Chemical Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. City Chemical Product
    Table 71. City Chemical Recent Development
    Table 72. 3B Scientific Corporation Information
    Table 73. 3B Scientific Description and Business Overview
    Table 74. 3B Scientific Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. 3B Scientific Product
    Table 76. 3B Scientific Recent Development
    Table 77. VWR International Corporation Information
    Table 78. VWR International Description and Business Overview
    Table 79. VWR International Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. VWR International Product
    Table 81. VWR International Recent Development
    Table 82. Pfaltz & Bauer Corporation Information
    Table 83. Pfaltz & Bauer Description and Business Overview
    Table 84. Pfaltz & Bauer Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Pfaltz & Bauer Product
    Table 86. Pfaltz & Bauer Recent Development
    Table 87. Kanto Chemical Corporation Information
    Table 88. Kanto Chemical Description and Business Overview
    Table 89. Kanto Chemical Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Kanto Chemical Product
    Table 91. Kanto Chemical Recent Development
    Table 92. J & K SCIENTIFIC Corporation Information
    Table 93. J & K SCIENTIFIC Description and Business Overview
    Table 94. J & K SCIENTIFIC Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. J & K SCIENTIFIC Product
    Table 96. J & K SCIENTIFIC Recent Development
    Table 97. Meryer (Shanghai) Chemical Technology Corporation Information
    Table 98. Meryer (Shanghai) Chemical Technology Description and Business Overview
    Table 99. Meryer (Shanghai) Chemical Technology Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Meryer (Shanghai) Chemical Technology Product
    Table 101. Meryer (Shanghai) Chemical Technology Recent Development
    Table 102. Energy Chemical Corporation Information
    Table 103. Energy Chemical Description and Business Overview
    Table 104. Energy Chemical Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. Energy Chemical Product
    Table 106. Energy Chemical Recent Development
    Table 107. Adamas Reagent Corporation Information
    Table 108. Adamas Reagent Description and Business Overview
    Table 109. Adamas Reagent Valeramide (CAS 626-97-1) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Adamas Reagent Product
    Table 111. Adamas Reagent Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Valeramide (CAS 626-97-1) Customers List
    Table 115. Valeramide (CAS 626-97-1) Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Valeramide (CAS 626-97-1) Product Picture
    Figure 2. Global Valeramide (CAS 626-97-1) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Valeramide (CAS 626-97-1) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Valeramide (CAS 626-97-1) Sales 2017-2028 (K MT)
    Figure 5. United States Valeramide (CAS 626-97-1) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Valeramide (CAS 626-97-1) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Valeramide (CAS 626-97-1) Sales 2017-2028 (K MT)
    Figure 8. United States Valeramide (CAS 626-97-1) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Valeramide (CAS 626-97-1) Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Valeramide (CAS 626-97-1) Report Years Considered
    Figure 11. Product Picture of Purity 97%
    Figure 12. Product Picture of Purity 98%
    Figure 13. Product Picture of Purity 99%
    Figure 14. Global Valeramide (CAS 626-97-1) Market Share by Type in 2022 & 2028
    Figure 15. Global Valeramide (CAS 626-97-1) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Valeramide (CAS 626-97-1) Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Valeramide (CAS 626-97-1) Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Valeramide (CAS 626-97-1) Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Valeramide (CAS 626-97-1) Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Valeramide (CAS 626-97-1) Market Share by Type in 2022 & 2028
    Figure 21. United States Valeramide (CAS 626-97-1) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Valeramide (CAS 626-97-1) Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Valeramide (CAS 626-97-1) Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Valeramide (CAS 626-97-1) Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Valeramide (CAS 626-97-1) Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Chemical Reagents
    Figure 27. Product Picture of Pharmaceutical Intermediates
    Figure 28. Product Picture of Others
    Figure 29. Global Valeramide (CAS 626-97-1) Market Share by Application in 2022 & 2028
    Figure 30. Global Valeramide (CAS 626-97-1) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Valeramide (CAS 626-97-1) Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Valeramide (CAS 626-97-1) Sales by Application (2017-2028) & (K MT)
    Figure 33. Global Valeramide (CAS 626-97-1) Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Valeramide (CAS 626-97-1) Price by Application (2017-2028) & (USD/MT)
    Figure 35. United States Valeramide (CAS 626-97-1) Market Share by Application in 2022 & 2028
    Figure 36. United States Valeramide (CAS 626-97-1) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Valeramide (CAS 626-97-1) Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Valeramide (CAS 626-97-1) Sales by Application (2017-2028) & (K MT)
    Figure 39. United States Valeramide (CAS 626-97-1) Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Valeramide (CAS 626-97-1) Price by Application (2017-2028) & (USD/MT)
    Figure 41. North America Valeramide (CAS 626-97-1) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 42. North America Valeramide (CAS 626-97-1) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Valeramide (CAS 626-97-1) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. Europe Valeramide (CAS 626-97-1) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Valeramide (CAS 626-97-1) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 53. Asia-Pacific Valeramide (CAS 626-97-1) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Valeramide (CAS 626-97-1) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 65. Latin America Valeramide (CAS 626-97-1) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Valeramide (CAS 626-97-1) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 70. Middle East & Africa Valeramide (CAS 626-97-1) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Valeramide (CAS 626-97-1) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Valeramide (CAS 626-97-1) Value Chain
    Figure 75. Valeramide (CAS 626-97-1) Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
TCI
Alfa Chemistry
Acros Organics
AlliChem
Waterstone Technology
City Chemical
3B Scientific
VWR International
Pfaltz & Bauer
Kanto Chemical
J & K SCIENTIFIC
Meryer (Shanghai) Chemical Technology
Energy Chemical
Adamas Reagent
Frequently Asked Questions
Valeramide (CAS 626-97-1) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Valeramide (CAS 626-97-1) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Valeramide (CAS 626-97-1) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

4-Hydroxypiperidine

4-Hydroxypiperidine market is segmented by region (country), players, by Type and by Application. ... Read More